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Clostridium
difficile in Retail
Meat Products,
USA, 2007
J. Glenn Songer, Hien T. Trinh,
George E. Killgore, Angela D. Thompson,
L. Clifford McDonald, and Brandi M. Limbago
To determine the presence of Clostridium difficile, we
sampled cooked and uncooked meat products sold in Tucson, Arizona. Forty-two percent contained toxigenic C. difficile strains (either ribotype 078/toxinotype V [73%] or 027/
toxinotype III [NAP1 or NAP1-related; 27%]). These findings
indicate that food products may play a role in interspecies
C. difficile transmission.

T

he incidence and severity of Clostridium difficile infections (CDIs) are increasing in North America (1), probably because of emergence of an epidemic strain (NAP1/
BI/027, toxinotype [TT] III) (2,3). C. difficile transmission
occurs primarily in healthcare facilities, but community-associated CDI (CA-CDI) appears to be increasing and may
now account for 20%–45% of positive diagnostic assay
results (4,5). Up to 35% of patients with CA-CDI report
no antimicrobial agent use within 3 months before disease
onset (4,5), although nonantimicrobial drugs (e.g., proton
pump inhibitors, nonsteroidal antiinflammatory agents) are
also implicated as risk factors (4). Sources of C. difficile
acquisition in community settings are unknown.
CDI is increasingly important in food animals (6). Infection rates of >95% have been documented among neonatal pigs in farrowing facilities, resulting in diarrhea and
typhlocolitis (6). Toxigenic C. difficile is also implicated as
a cause of diarrhea in calves (7). C. difficile was identified
in raw meat intended for pet consumption (8) and in ≈20%
of retail ground beef in Canada (9). We report the isolation
of C. difficile from uncooked and ready-to-eat meats in retail markets in a US metropolitan area.
The Study
Packaged meats were purchased from 3 national-chain
grocery stores in the Tucson, Arizona, area on 3 occasions
at 1-month intervals from January to April 2007. ProdAuthor affiliations: University of Arizona, Tucson, Arizona, USA
(J.G. Songer, H.T. Trinh); and Centers for Disease Control and Prevention, Atlanta, Georgia, USA (G.E. Killgore, A.D. Thompson, L.C.
McDonald, B.M. Limbago)
DOI: 10.3201/eid1505.081071

ucts sampled were both uncooked (ground beef, ground
pork, ground turkey, pork sausage, and pork chorizo) and
ready to eat (beef summer sausage, pork braunschweiger)
(Table). Pork chorizo was produced and distributed locally;
all other samples were national brands. Products with different sell-by dates (a surrogate for production date) were
sampled for each meat type. Samples were not representative of all meat products in each grocery store.
For each sample, 1 g of meat was added to two 10mL tubes of prereduced brain heart infusion (BD, Franklin
Lakes, NJ, USA), which had been supplemented with 0.5%
yeast extract (BD), 0.05% DL-cysteine (Sigma-Aldrich, St.
Louis, MO, USA), and 0.1% taurocholate (MP Biomedicals, Solon, OH, USA). One tube was heat shocked (80°C,
10 min), and both were then incubated anaerobically at
37°C for 72 h. Aliquots were subcultured onto taurocholate
cycloserine cefoxitin fructose agar (TCCFA) (10) and incubated anaerobically for 24–72 h at 37°C. Colonies were
subcultured onto anaerobic blood agar, TCCFA (with or
without antimicrobial agents), and confirmed as C. difficile
by p-cresol odor, yellow-green fluorescence under UV illumination, a positive L-proline aminopeptidase reaction,
and negative indole reaction.
Isolates were characterized by PCR ribotyping (11),
toxinotyping (3), and pulsed-field gel electrophoresis
(PFGE) (12). Presence of tcdA, tcdB, cdtB (binary toxin),
and deletions in tcdC was determined by PCR (2).
MICs were determined by Etest (AB Biodisk, Solna,
Sweden) on Brucella blood agar with vitamin K and hemin
(Remel, Lenexa, KS, USA) that was incubated anaerobically at 35°C. Reference interpretive criteria for C. difficile
susceptibility to clindamycin and moxifloxacin were used;
MICs for levofloxacin and gatifloxacin were interpreted
by using criteria for moxifloxacin (13). Bacteroides fragilis ATCC 25285, B. thetaiotaomicron ATCC 29741, C.
difficile ATCC 700057, and Enterococcus faecalis ATCC
29212 were included as controls.
Proportions were compared by χ2 or Fisher exact test.
Thirty-seven (42.0%) of 88 retail meats yielded C. difficile,
including 42.4% of beef, 41.3% of pork, and 44.4% of turkey products (Table). Ready-to-eat products were more
commonly culture positive (11/23; 47.8%) than were uncooked meats (26/65; 40.0%), although the difference was
not significant (p = 0.34). The highest percentages of C.
difficile isolates were recovered from pork braunschweiger
(62.5%) and ground beef (50.0%). Culture-positive results
came from both heat-shocked and non–heat-shocked cultures, whereas culture-negative specimens were negative
in both types of culture, and no specimen was positive by
both methods (not shown). No association was found with
the meat processor, the sell-by date, the store, or the month
sampled (not shown). Multiple independent cultures from 2
braunschweiger samples yielded indistinguishable isolates
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Table. Source and characteristics of Clostridium difficile isolates obtained from retail meats sold in Tuscon, Arizona, USA, 2007*
Meat product
No. samples Total no. (%) Ribotype Toxinotype ǻtcdC, bp†
PFGE type
No. (%) pos
cultured
positive
Ground beef (uncooked)
26
13 (50)
027
III
18
NAP1
1 (3.8)
NAP1-related
2 (7.7)
078
V
39
NAP7
8 (30.8)
NAP8
2 (7.7)
Summer sausage (ready to eat)
7
1 (14.3)
027
III
18
NAP1
1 (14.3)
Ground pork (uncooked)
7
3 (42.9)
027
III
18
NAP1-related
1 (14.3)
078
V
39
NAP7
2 (28.6)
Braunschweiger (ready to eat)
16
10 (62.5)
027
III
18
NAP1
2 (12.5)
NAP1-related
1 (6.2)
078
V
39
NAP7
7 (43.8)
Chorizo (uncooked)
10
3 (30.0)
027
III
18
NAP1-related
1 (10.0)
078
V
39
NAP7
2 (20.0)
Pork sausage (uncooked)
13
3 (23.1)
027
III
18
NAP1-related
1 (7.7)
078
V
39
NAP7
2 (15.4)
Ground turkey (uncooked)
9
4 (44.4)
078
V
39
NAP7
4 (44.4)
Totals
88
37 (42.0)
027
III
18
NAP1
4 (4.4)
NAP1-related
6 (6.7)
078
V
39
NAP7
25 (27.8)
NAP8
2 (2.2)
*All samples were positive for cdtB, which encodes the binding component of binary toxin. PFGE, pulsed-field gel electrophoresis.
†Deletions in tcdC regulatory gene.

in the same meat sample (10/10 from 1 package and 12/12
from another; not shown), which suggests that a single
strain may predominate when C. difficile is present. Our
percentage of recovery of C. difficile from retail meat products is higher than that reported (20%) in a similar study of
Canadian ground beef (9), possibly because of differences
in culture methods, the meats sampled, or national or geographic variation.
Isolates were grouped into ribotype 078/TT V (27/37,
73.0%) and ribotype 027/TT III (10/37, 27.0%). Strain
types were not specific to meat type, store, or sampling
month (Table). All isolates were PCR positive for binary
toxin (cdtB), tcdA, and tcdB. Characteristic 18-bp and 39bp deletions in tcdC were present in 027/TT III and 078/
TT V isolates, respectively (2,12). PFGE divided 027/ TT
III isolates into NAP1 (>80% related to human NAP1) and
NAP1-related (78% related to human NAP1) groups and
078/TT V isolates into NAP7 and NAP8 groups (Figure).
Ribotype 027 isolates are described almost exclusively
in context of the current human epidemic strain, NAP1/027/
TT III (2). In this study, we also found 027/TT III isolates
that were only 78% similar to NAP1 (i.e., NAP1-related).
Ribotype 078 strains were previously uncommon causes
of healthcare-associated CDI in humans (12), but now
they are emerging in pigs and calves with diarrhea (7; J.S.
Weese, pers. comm.) and in persons with CDI (12). Two
epidemiologically unrelated 078/TT V isolates from human CDI patients are indistinguishable by PFGE from pig
isolates (12).
The 078/TT V isolates were uniformly susceptible to
levofloxacin, moxifloxacin, and gatifloxacin. Like human
820

TT V isolates (12), most 078/TT V meat isolates were nonsusceptible to clindamycin (56% resistant, 41% intermediate). This may not be surprising given the widespread use
of tylosin, erythromycin, virginiamycin, and lincomycin in
food animals and the potential for selection of macrolidelincosamide-streptogramin resistance (14).
NAP1 isolates have demonstrated high-level resistance to levofloxacin, moxifloxacin, gatifloxacin (>32 μg/
mL), and clindamycin (>256 μg/mL), consistent with current human strains (2). NAP1-related isolates were susceptible to levofloxacin, moxifloxacin, and gatifloxacin
but resistant to clindamycin, similar to the pattern of historic NAP1 strains (2).
Conclusions
Fluoroquinolones are widely used in human therapy,
and the current epidemic strain may have emerged because
of its resistance to these agents. Fluoroquinolone use is
limited in food animal production (14), with the exception
of enrofloxacin for treatment of bovine respiratory disease
(now approved for use in swine).
The source of C. difficile in retail meats may involve
antemortem deposition of spores in the animal’s muscle or
other tissues, fecal or environmental contamination of carcasses, or contamination during processing. Spores could
persist in packing plants, resulting in contamination of carcasses or food products during processing. Contamination
may also occur in retail meat markets.
Direct or indirect human-to-human transmission is responsible for most healthcare-related CDIs (15) and most
likely contributes to CA-CDI. Therefore, stopping such
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